Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FS2FC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,017
Award facts
- Contract value 100% obligated
- $11,017.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,017.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. The place of performance is located in Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The broader IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering branded and generic prescription drugs, biologics, medical consumables, and specialty pharmaceutical products including oncology treatments and vaccines.
Quick answers
Who was awarded contract SPE2DB25FS2FC?
SPE2DB25FS2FC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FS2FC worth?
The government has obligated $11,017 on SPE2DB25FS2FC.
Is contract SPE2DB25FS2FC an order under another contract?
Yes. SPE2DB25FS2FC is a delivery order under SPE2DB22D9247, an indefinite delivery contract.
Was contract SPE2DB25FS2FC competed?
The extent of competition for SPE2DB25FS2FC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award